fluticasone

(redirected from Breo Ellipta)
Also found in: Medical.
Related to Breo Ellipta: Advair
Translations

fluticasone

n fluticasona
References in periodicals archive ?
Milton depends on free samples provided by her doctor for her prescription of Breo Ellipta - the supply is limited, so she regularly skips one of the two daily doses.
Breo Ellipta (fluticasone furoate/vilanterol; GSK): How concerned are doctors about Breo Ellipta's cost and insurance restrictions?
M2 EQUITYBITES-August 10, 2015-GlaxoSmithKline receives Canadian approval for Breo Ellipta
The FDA approved the 100-mcg/25-mcg dose in 2013 to treat chronic obstructive pulmonary disease; GSK markets it as Breo Ellipta.
Food & Drug Administration (FDA) has approved the drug Breo Ellipta for treatment of chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema.
In the regional portfolio, shares in GLAXOSMITHKLINE traded higher after the US Food & Drug Administration (FDA) granted approval for Breo Ellipta, as a treatment for chronic obstructive pulmonary disease (COPD).
The innovative study, which reported headline results in May 2017, showed that initiation of once-daily Relvar Ellipta (fluticasone furoate FF/vilanterol VI or FF/VI, called Breo Ellipta in the U.
GSK plans to market the product as Breo Ellipta if it is approved.
One demonstrated that patients with Chronic Obstructive Pulmonary Disease (COPD) and moderate airflow limitation receiving Breo Ellipta (fluticasone furoate/vilanterol or FF/VI 100/25mcg) achieved improvements in exacerbations compared with placebo.
M2 PHARMA-August 10, 2015-GlaxoSmithKline receives Canadian approval for Breo Ellipta
M2 EQUITYBITES-May 1, 2015-GlaxoSmithKline passes US FDA's approval of BREO ELLIPTA for treating adults with asthma in the US